Takeda Pharmaceuticals has stated that they will be cutting nine percent of their workforce in order to make up for an 11-year low in profits.
The company will be cutting 2,800 jobs over a four year period and this will take place mainly in the U.S. and Europe. The drug maker is hoping that the cut back in jobs will help them to save 130 million yen in net savings by March 2016.
The Japan-based company has stated that the plan will be cut 35 billion yen from the financial plan for the current year. A healthcare analyst has stated that he is unsure if this cut back is enough to make up for what has been lost on the company’s Actos sales. Actos, a popular type 2 diabetes medication, has been linked to the development of bladder cancer when taken for over a year.
If this has happened to you or someone you love, you need representation that may be able to help you fight for the compensation you deserve. Contact the Actos bladder cancer lawsuit lawyers of Williams Kherkher by calling 800-641-9810.